|
|
||||||||
Division of Molecular Medicine, Wadsworth Center, New York State Department of Health, Empire State Plaza, Albany, NewYork 12201
Mammalian alpha-fetoprotein (AFP) is classified as a member of the albuminoid gene superfamily consisting of albumin, AFP, vitamin D (Gc) protein, and alpha-albumin. Molecular variants of AFP have long been reported in the biomedical literature. Early studies identified isoelectric pH isoforms and lectin-binding variants of AFP, which differed in their physicochemical properties, but not in amino acid composition. Genetic variants of AFP, differing in mRNA kilobase length, were later extensively described in rodent models during fetal/perinatal stages, carcinogenesis, and organ regeneration. With the advent of monoclonal antibodies in the early 1980s, multiple antigenic epitopes on native AFP were detected and categorized, culminating in the identification of six to seven major epitopes. During this period, various AFP-binding proteins and receptors were reported to inhibit certain AFP immunoreactions. Concomittantly, human and rodent AFP were cloned and the amino acid sequences of the translated proteins were divulged. Once the amino acid composition of the AFP molecule was known, enzymatic fragments could be identified and synthetic peptide segments synthesized. Following discovery of the molten globule form in 1981, the existence of transitory, intermediate forms of AFP were acknowledged and their physiological significance was realized. In the present review, the various isoforms and variants of AFP are discussed in light of their potential biological relevance.
Key Words: alpha-fetoprotein isoforms epitopes variants conformation structure function
This article has been cited by other articles:
![]() |
G. J. Mizejewski Physiology of Alpha-Fetoprotein as a Biomarker for Perinatal Distress: Relevance to Adverse Pregnancy Outcome Experimental Biology and Medicine, September 1, 2007; 232(8): 993 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C.S. Smith, A. M. Wood, J. P. Pell, I. R. White, J. A. Crossley, and R. Dobbie Second-Trimester Maternal Serum Levels of Alpha-Fetoprotein and the Subsequent Risk of Sudden Infant Death Syndrome N. Engl. J. Med., September 2, 2004; 351(10): 978 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-A. S. Pfandler, M. Hochli, D. Inderbitzin, P. J. Meier, and B. Stieger Small hepatocytes in culture develop polarized transporter expression and differentiation J. Cell Sci., August 15, 2004; 117(18): 4077 - 4087. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Mizejewski Biological Roles of Alpha-Fetoprotein During Pregnancy and Perinatal Development Experimental Biology and Medicine, June 1, 2004; 229(6): 439 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Mizejewski and R. MacColl {alpha}-Fetoprotein growth inhibitory peptides: Potential leads for cancer therapeutics Mol. Cancer Ther., November 1, 2003; 2(11): 1243 - 1255. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |